Paul Manning

In 2017, Paul Manning co-founded biotechnology firm, Helius Therapeutics, focused on researching, developing and commercialising medicinal cannabis. In 2018 we raise $15m in our Series A & B capital rounds and in 2020 we raised a further $20m, taking our market cap to $105m. Today, Helius is New Zealand's largest licensed medicinal cannabis company.